Literature DB >> 23776176

Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.

Olivia Bonduelle1, Nora Yahia, Sophie Siberil, Nora Benhabiles, Fabrice Carrat, Anne Krivine, Flore Rozenberg, Jordan Dimitrov, Srini V Kaveri, Angélique Curjol, Malka Tindel, Martine Louet, Florent Desert, Odile Launay, Pierre Loulergue, Gwenaelle Badre, Christine Katlama, François Bricaire, Assia Samri, Dominique Rousset, Sylvie van der Werf, Stephane Jauréguiberry, Behazine Combadiere.   

Abstract

Most vaccines, including those against influenza, were developed by focusing solely on humoral response for protection. However, vaccination activates different adaptive compartments that might play a role in protection. We took advantage of the pandemic 2009 A(H1N1) influenza vaccination to conduct a longitudinal integrative multiparametric analysis of seven immune parameters in vaccinated subjects. A global analysis underlined the predominance of induction of humoral and CD4 T cell responses, whereas pandemic 2009 A(H1N1)-specific CD8 responses did not improve after vaccination. A principal component analysis and hierarchical clustering of individuals showed a differential upregulation of influenza vaccine-specific immunity including hemagglutination inhibition titers, IgA(+) and IgG(+) Ab-secreting cells, effector CD4 or CD8 T cell frequencies at day 21 among individuals, suggesting a fine-tuning of the immune parameters after vaccination. This is related to individual factors including the magnitude and quality of influenza-specific immune responses before vaccination. We propose a graphical delineation of immune determinants that would be essential for a better understanding of vaccine-induced immunity in vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23776176     DOI: 10.4049/jimmunol.1203483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Authors:  Hiroko Matsumoto; Satoko Ohfuji; Kenji Watanabe; Hirokazu Yamagami; Wakaba Fukushima; Kazuhiro Maeda; Noriko Kamata; Mitsue Sogawa; Masatsugu Shiba; Tetsuya Tanigawa; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Yoshio Hirota; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2015-02-12       Impact factor: 7.527

2.  Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.

Authors:  Eléna Gonçalves; Olivia Bonduelle; Angèle Soria; Pierre Loulergue; Alexandra Rousseau; Marine Cachanado; Henri Bonnabau; Rodolphe Thiebaut; Nicolas Tchitchek; Sylvie Behillil; Sylvie van der Werf; Annika Vogt; Tabassome Simon; Odile Launay; Behazine Combadière
Journal:  J Clin Invest       Date:  2019-03-07       Impact factor: 14.808

3.  Characterization of pandemic influenza immune memory signature after vaccination or infection.

Authors:  Olivia Bonduelle; Fabrice Carrat; Charles-Edouard Luyt; Catherine Leport; Anne Mosnier; Nora Benhabiles; Anne Krivine; Flore Rozenberg; Nora Yahia; Assia Samri; Dominique Rousset; Sylvie van der Werf; Brigitte Autran; Behazine Combadiere
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

Review 4.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

5.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

6.  The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.

Authors:  Anna M Powell; Zhenwu Luo; Lisa Martin; Zhuang Wan; Lei Ma; Guoyang Liao; Yuxia Song; Xiaochun Li; J Michael Kilby; Lei Huang; Wei Jiang
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

7.  Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.

Authors:  Christoph T Berger; Victor Greiff; Matthias Mehling; Stefanie Fritz; Marc A Meier; Gideon Hoenger; Anna Conen; Mike Recher; Manuel Battegay; Sai T Reddy; Christoph Hess
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.

Authors:  Ping Ma; Zhenwu Luo; Jing Qian; Zhongfang Yan; Lumin Zhang; Lisa Martin; Ziyu Wang; Huan Xia; Fangfang Yu; Wei Jiang
Journal:  Vaccine       Date:  2020-01-14       Impact factor: 3.641

Review 9.  Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.

Authors:  Saranya Sridhar
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

10.  Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years.

Authors:  Mai-Chi Trieu; Fan Zhou; Sarah Larteley Lartey; Saranya Sridhar; Siri Mjaaland; Rebecca Jane Cox
Journal:  NPJ Vaccines       Date:  2018-08-14       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.